Nu-Med Plus Inc
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers; a mobile rechargeable device to deliver nitric oxide gas; and a nitric ox… Read more
Market Cap & Net Worth: Nu-Med Plus Inc (NUMD)
Nu-Med Plus Inc (OTCQB:NUMD) has a market capitalization of $6.10 Million ($6.10 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #34206 globally and #11148 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nu-Med Plus Inc's stock price $0.07 by its total outstanding shares 83548469 (83.55 Million).
Nu-Med Plus Inc Market Cap History: 2015 to 2025
Nu-Med Plus Inc's market capitalization history from 2015 to 2025. Data shows change from $78.54 Million to $6.10 Million (-17.54% CAGR).
Nu-Med Plus Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nu-Med Plus Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
-5250.22x
Nu-Med Plus Inc's market cap is -5250.22 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $33.42 Million | $4.38 Billion | $100.86 Million | 0.01x | 0.33x |
| 2020 | $75.19 Million | $-14.32K | -$2.01 Million | -5250.22x | N/A |
Competitor Companies of NUMD by Market Capitalization
Companies near Nu-Med Plus Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Nu-Med Plus Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Nu-Med Plus Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Nu-Med Plus Inc's market cap moved from $78.54 Million to $ 6.10 Million, with a yearly change of -17.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.10 Million | +268.69% |
| 2024 | $1.65 Million | -50.99% |
| 2023 | $3.38 Million | +144.85% |
| 2022 | $1.38 Million | -52.86% |
| 2021 | $2.92 Million | -96.11% |
| 2020 | $75.19 Million | +100.00% |
| 2019 | $37.60 Million | -40.00% |
| 2018 | $62.66 Million | +87.50% |
| 2017 | $33.42 Million | +60.00% |
| 2016 | $20.89 Million | -73.40% |
| 2015 | $78.54 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nu-Med Plus Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.10 Million USD |
| MoneyControl | $6.10 Million USD |
| MarketWatch | $6.10 Million USD |
| marketcap.company | $6.10 Million USD |
| Reuters | $6.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.